Peptide-based PET tracer targeting LAG-3 for evaluating the efficacy of immunotherapy in melanoma
Background Lymphocyte activation gene 3 (LAG-3) is expressed on activated immune cells and has emerged as a promising target for immune checkpoints blockade. However, conflicting findings have been reported regarding the association between LAG-3 expression in tumors and patient prognosis, indicatin...
Saved in:
| Main Authors: | Yan Wang, Ziyang Zhu, Peizhe Yuan, Yu Long, Nannan Wei, Jinquan Han, Dawei Jiang, Xiaoli Lan, Yongkang Gai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-07-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/12/7/e009010.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination immunotherapy targeting LAG-3, PD-1 and STING suppresses hepatocellular carcinoma as monitored by LAG-3 targeted PET imaging
by: Zhen Quan, et al.
Published: (2025-08-01) -
Lag-3 expression and clinical outcomes in metastatic melanoma patients treated with combination anti-lag-3 + anti-PD-1-based immunotherapies
by: Tuba N. Gide, et al.
Published: (2023-12-01) -
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma
by: Sydney Ch’ng, et al.
Published: (2025-03-01) -
Promising immunotherapy targets: TIM3, LAG3, and TIGIT joined the party
by: Chenyu Lu, et al.
Published: (2024-03-01) -
Synthesis and preliminary biological evaluation of a novel PET tracer for α-synuclein PET imaging
by: WANG Ce, et al.
Published: (2024-10-01)